Enhancing Antibody Development: Leveraging FcRn Transgenic Mice (tg32) for Drug Discovery of Therapeutic Antibodies
Presented by Martin Lechmann Ph.D., DMPK/PD Project Lead (DPL) Biologics, Roche Diagnostics GmbH
Presented by Martin Lechmann Ph.D., DMPK/PD Project Lead (DPL) Biologics, Roche Diagnostics GmbH